Hideo Yonezawa

Dr. Hideo Yonezawa

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2009 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
HYHideo Yonezawa
Hideo Yonezawa
TOTakako Osaki
Takako Osaki
SKSatoshi Kurata
Satoshi Kurata
MFMinoru Fukuda
Minoru Fukuda
HKHayato Kawakami
Hayato Kawakami
SKShigeru Kamiya
Shigeru Kamiya
Helicobacter pylori forms biofilms on glass surfaces at the air-liquid interface in in vitro batch cultures; however, biofilms of H. pylori have not been well characterized. In the present study, we analyzed the ability of H. pylori strains to form biofilms and characterized the underlying mechanisms of H. pylori biofilm formation. Strain TK1402 showed strong biofilm forming ability relative to the other strains in Brucella broth supplemented with 7% FCS. The strong biofilm forming ability of TK1402 is reflected the relative thickness of the biofilms. In addition, outer membrane vesicles (OMV) were detected within the matrix of only the TK1402 biofilms. Biofilm formation was strongly correlated with the production of OMV in this strain. We further observed that strain TK1402 did not form thick biofilms in Brucella broth supplemented with 0.2% β-cyclodextrin. However, the addition of the OMV-fraction collected from TK1402 could enhance biofilm formation. The results suggested that OMV produced from TK1402 play an important role in biofilm formation in strain TK1402.

1 January 2015 in BioMed Research International
Verified
Journal Article
Open access
PDF file
HYHideo Yonezawa
Hideo Yonezawa
TOTakako Osaki
Takako Osaki
SKShigeru Kamiya
Shigeru Kamiya
Bacterial biofilms are communities of microorganisms attached to a surface. Biofilm formation is critical not only for environmental survival but also for successful infection.Helicobacter pyloriis one of the most common causes of bacterial infection in humans. Some studies demonstrated that this microorganism has biofilm forming ability in the environment and on human gastric mucosa epithelium as well as onin vitroabiotic surfaces. In the environment,H. pyloricould be embedded in drinking water biofilms through water distribution system in developed and developing countries so that the drinking water may serve as a reservoir forH. pyloriinfection. In the human stomach,H. pyloriforms biofilms on the surface of gastric mucosa, suggesting one possible explanation for eradication therapy failure. Finally, based on the results ofin vitroanalyses,H. pyloribiofilm formation can decrease susceptibility to antibiotics andH. pyloriantibiotic resistance mutations are more frequently generated in biofilms than in planktonic cells. These observations indicated thatH. pyloribiofilm formation may play an important role in preventing and controllingH. pyloriinfections. Therefore, investigation ofH. pyloribiofilm formation could be effective in elucidating the detailed mechanisms of infection and colonization by this microorganism.

6 September 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HYHideo Yonezawa
Hideo Yonezawa
TOTakako Osaki
Takako Osaki
THTomoko Hanawa
Tomoko Hanawa
SKSatoshi Kurata
Satoshi Kurata
KOKuniyasu Ochiai
Kuniyasu Ochiai
SKShigeru Kamiya
Shigeru Kamiya
The human gastric pathogen Helicobacter pylori forms biofilms in vitro and in vivo. The purpose of this study was to evaluate the effects of H. pylori biofilm formation in vitro on clarithromycin (CLR) susceptibility. CLR susceptibility of H. pylori intermediate (2-day) and mature (3-day) biofilms on glass coverslips was determined at concentrations from 0.03 to 0.5 µg/ml. H. pylori biofilm biomass was increased after treatment with CLR at minimum inhibitory concentration levels by up to 4-fold (2-day biofilm) and 16-fold (3-day biofilm). Minimum bactericidal concentrations of CLR against cells in a biofilm were higher (1.0 µg/ml) than that for planktonic cells (0.25 µg/ml). It was shown that the expression of efflux pump genes was significantly increased in biofilm cells. In addition, exposure of biofilms to CLR resulted in high level resistance generation compared to planktonic cells with increased resistance associated with the presence of a point mutation at either position 2142 or 2143 in the domain V loop of the 23S rRNA gene. These results demonstrate that H. pylori biofilm formation decreases the susceptibility to CLR and that H. pylori CLR resistance mutations are more frequently generated in biofilms than in planktonic cells.

1 July 2019 in Microbial Pathogenesis
Verified
Journal Article
Closed access
HYHideo Yonezawa
Hideo Yonezawa
TOTakako Osaki
Takako Osaki
FHFuhito Hojo
Fuhito Hojo
SKShigeru Kamiya
Shigeru Kamiya

24 July 2020 in Toxins
Verified
Journal Article
Open access
PDF file
KFKartika Afrida Fauzia
Kartika Afrida Fauzia
MMMuhammad Miftahussurur
Muhammad Miftahussurur
ASAri Syam
Ari Syam
LWLanggeng Agung Waskito
Langgeng Agung Waskito
DDDalla Doohan
Dalla Doohan
Yoshio YamaokaYoshio Yamaoka
Yoshio Yamaoka
We evaluated biofilm formation of clinical Helicobacter pylori isolates from Indonesia and its relation to antibiotic resistance. We determined the minimum inhibition concentration (MIC) of amoxicillin, clarithromycin, levofloxacin, metronidazole and tetracycline by the Etest to measure the planktonic susceptibility of 101 H. pylori strains. Biofilms were quantified by the crystal violet method. The minimum biofilm eradication concentration (MBEC) was obtained by measuring the survival of bacteria in a biofilm after exposure to antibiotics. The majority of the strains formed a biofilm (93.1% (94/101)), including weak (75.5%) and strong (24.5%) biofilm-formers. Planktonic resistant and sensitive strains produced relatively equal amounts of biofilms. The resistance proportion, shown by the MBEC measurement, was higher in the strong biofilm group for all antibiotics compared to the weak biofilm group, especially for clarithromycin (p = 0.002). Several cases showed sensitivity by the MIC measurement, but resistance according to the MBEC measurements (amoxicillin, 47.6%; tetracycline, 57.1%; clarithromycin, 19.0%; levofloxacin, 38.1%; and metronidazole 38.1%). Thus, biofilm formation may increase the survival of H. pylori and its resistance to antibiotics. Biofilm-related antibiotic resistance should be evaluated with antibiotic susceptibility.

23 April 2010 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
HYHideo Yonezawa
Hideo Yonezawa
TOTakako Osaki
Takako Osaki
SKSatoshi Kurata
Satoshi Kurata
CZCynthia Zaman
Cynthia Zaman
THTomoko Hanawa
Tomoko Hanawa
SKShigeru Kamiya
Shigeru Kamiya